Posted On: May 15, 2023

Today, Amazon Omics announces the availability of Ready2Run workflows, a set of pre-built workflows from third-party software companies and open-source pipelines. With just a few clicks or a single API call, customers can run pre-built pipelines to perform primary analysis such as converting base calls to FASTQ files, secondary analysis such as gene expression or variant calling, and tertiary analysis such as protein structure prediction. Ready2Run workflows are priced-per-run to give customers predictable pricing. We are launching with 35 Ready2Run workflows, which are a combination of workflows built by Element Biosciences, NVIDIA, and Sentieon Inc, as well as popular open-source pipelines developed by the life sciences community.

Amazon Omics is a fully managed service that helps healthcare and life science organizations build at-scale to store, query, and analyze genomic, transcriptomic, and other omics data. By removing the undifferentiated heavy lifting, customers can generate deeper insights from omics data to improve health and advance scientific discoveries.

Ready2Run workflows are available in all AWS Regions where Amazon Omics is generally available: US East (N. Virginia), US West (Oregon), Europe (Frankfurt, Ireland, London), and Asia Pacific (Singapore).

For more information on Ready2Run workflows, read the launch blog or get started by visiting the Amazon Omics console. If you are interested in collaborating with AWS to build new Ready2Run workflows on Amazon Omics, contact the AWS Ready2Run team.